BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1512 related articles for article (PubMed ID: 25282526)

  • 1. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis, cannabidiol, and epilepsies: the truth is somewhere in the middle.
    Sirven JI
    Epilepsy Behav; 2014 Dec; 41():270-1. PubMed ID: 25248668
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
    Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping cannabis potency in medical and recreational programs in the United States.
    Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
    PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cannabidiol and Δ9-tetrahydrocannabinol, alone and in combination, in the maximal electroshock seizure model.
    Dlugosz L; Zhou HZ; Scott BW; Burnham M
    Epilepsy Res; 2023 Feb; 190():107087. PubMed ID: 36646020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG; Hallak JEC; Crippa JAS
    Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marijuana use among patients with epilepsy at a tertiary care center.
    Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
    Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting cannabis products to pharmaceutical drugs.
    Koltai H; Poulin P; Namdar D
    Eur J Pharm Sci; 2019 Apr; 132():118-120. PubMed ID: 30851400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.